Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02795052Not ApplicableRecruiting

Neurologic Stem Cell Treatment Study

Role: lead

NCT06613971Recruiting

Dynamic Light Scattering Ocular Measurement in the Detection of Dementia

Role: lead

NCT03011541Not ApplicableRecruiting

Stem Cell Ophthalmology Treatment Study II

Role: lead

NCT03225625Not ApplicableEnrolling By Invitation

Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study

Role: lead

NCT03724136Not ApplicableEnrolling By Invitation

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

Role: lead

NCT01920867Not ApplicableUnknown

Stem Cell Ophthalmology Treatment Study

Role: lead

All 6 trials loaded